Blumberg N - Search Results

1

Sickle red blood cells are more susceptible to in vitro haemolysis when exposed to normal saline versus Plasma-Lyte A.

Blumberg N, Henrichs K, Cholette J, Pietropaoli A, Spinelli S, Noronha S, Phipps R, Refaai MA. Blumberg N, et al. Vox Sang. 2019 May;114(4):325-329. doi: 10.1111/vox.12777. Epub 2019 Apr 2. Vox Sang. 2019. PMID: 30937917

2

A rapid and accurate single-drop modification of the acid-elution technique for detecting fetomaternal hemorrhage.

Corsetti JP, Cowles JW, Cox MT, Blumberg N. Corsetti JP, et al. Among authors: blumberg n. Vox Sang. 1988;54(1):39-42. doi: 10.1111/j.1423-0410.1988.tb01610.x. Vox Sang. 1988. PMID: 3348021

3

The causes and treatment of reactions to platelet transfusions.

Blumberg N, Phipps RP, Kaufman J, Heal JM. Blumberg N, et al. Transfusion. 2003 Feb;43(2):291-2; author reply 292. doi: 10.1046/j.1537-2995.2003.t01-2-00362.x. Transfusion. 2003. PMID: 12559029 No abstract available.

4

Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes.

Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP. Koumas L, et al. Among authors: blumberg n. Am J Pathol. 2003 Oct;163(4):1291-300. doi: 10.1016/S0002-9440(10)63488-8. Am J Pathol. 2003. PMID: 14507638 Free PMC article.

5

Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes.

Akbiyik F, Ray DM, Gettings KF, Blumberg N, Francis CW, Phipps RP. Akbiyik F, et al. Among authors: blumberg n. Blood. 2004 Sep 1;104(5):1361-8. doi: 10.1182/blood-2004-03-0926. Epub 2004 May 6. Blood. 2004. PMID: 15130939 Free article.

6

Platelets as a novel target for PPARgamma ligands : implications for inflammation, diabetes, and cardiovascular disease.

Ray DM, Spinelli SL, O'Brien JJ, Blumberg N, Phipps RP. Ray DM, et al. Among authors: blumberg n. BioDrugs. 2006;20(4):231-41. doi: 10.2165/00063030-200620040-00004. BioDrugs. 2006. PMID: 16831022 Review.

7

An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions.

Blumberg N, Gettings KF, Turner C, Heal JM, Phipps RP. Blumberg N, et al. Transfusion. 2006 Oct;46(10):1813-21. doi: 10.1111/j.1537-2995.2006.00979.x. Transfusion. 2006. PMID: 17002639 Clinical Trial.

8

The platelet as a therapeutic target for treating vascular diseases and the role of eicosanoid and synthetic PPARgamma ligands.

O'Brien JJ, Ray DM, Spinelli SL, Blumberg N, Taubman MB, Francis CW, Wittlin SD, Phipps RP. O'Brien JJ, et al. Among authors: blumberg n. Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):68-76. doi: 10.1016/j.prostaglandins.2006.05.018. Epub 2006 Jul 10. Prostaglandins Other Lipid Mediat. 2007. PMID: 17164134 Review.

9

Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion.

Kaufman J, Spinelli SL, Schultz E, Blumberg N, Phipps RP. Kaufman J, et al. Among authors: blumberg n. J Thromb Haemost. 2007 Apr;5(4):788-96. doi: 10.1111/j.1538-7836.2007.02412.x. J Thromb Haemost. 2007. PMID: 17403203 Free article.

10

Developmental changes in soluble CD40 ligand.

Cholette JM, Blumberg N, Phipps RP, McDermott MP, Gettings KF, Lerner NB. Cholette JM, et al. Among authors: blumberg n. J Pediatr. 2008 Jan;152(1):50-4, 54.e1. doi: 10.1016/j.jpeds.2007.06.036. Epub 2007 Oct 24. J Pediatr. 2008. PMID: 18154898 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters